Steven Samuel Rosenfeld MD
Neurooncology
Professor of Neurology, Cleveland Cl College of Medicine/Case West Res
Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Neurology, 1986 - 1989- Duke University HospitalInternship, Internal Medicine, 1985 - 1986
Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 2017 - 2027
OH State Medical License 2011 - 2026
NY State Medical License 2005 - 2022
AL State Medical License 1990 - 2005
NC State Medical License 1987 - 1998
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors Start of enrollment: 2001 Jul 01
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Feb 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
Publications & Presentations
PubMed
- Non-muscle myosin II is a promising therapeutic target.Courtney A Miller, Alfredo Quinones-Hinojosa, Steven S Rosenfeld
Trends in Pharmacological Sciences. 2025-10-01 - 1 citationsPredictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.Harshvardhan G Iyer, Ogechukwu K Ariwodo, Chase Mckevitt, Paola Suarez Meade, Lina Marenco-Hillembrand
Journal of Neuro-Oncology. 2025-09-01 - 6 citationsFrom the Operating Room to the Laboratory: Role of the Neuroscience Tissue Biorepository in the Clinical, Translational, and Basic Science Research Pipeline.Alfredo Quiñones-Hinojosa, Aleeshba Basil, Diogo Moniz-Garcia, Paola Suarez-Meade, Andres Ramos
Mayo Clinic Proceedings. 2024-02-01
Grant Support
- Generating Synthetic Lethality in Glioblastoma with a First-In-Class Non-Muscle Myosin II InhibitorMAYO CLINIC JACKSONVILLE2025–2029
- MT-125 for the Therapeutic Treatment of GlioblastomaMYOSIN THERAPEUTICS INC.2023–2025
- Targeting Go and Grow in GlioblastomaMAYO CLINIC JACKSONVILLE2020–2025
- Developing nonmuscle myosin II inhibitors for the treatment of glioblastomaUNIVERSITY OF FLORIDA2021–2024
- Myosin II And Glioma DispersionNational Institute Of Neurological Disorders And Stroke2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
